Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of ERCC4 (XPF) gene rs6498486 polymorphism and its potential role in breast cancer risk among Bangladeshi women. | BMC Cancer | 2026 | 41699509 | PubTator, text mining | PubMed |
| Pre-incision structures reveal principles of DNA nucleotide excision repair. | Nature | 2026 | 41673165 | PubTator, text mining | PubMed |
| The interaction of XPG with TFIIH through p62 and XPD is required for the completion of nucleotide excision repair. | Nucleic Acids Res | 2026 | 41641700 | PubTator, text mining | PubMed |
| Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment. | Elife | 2026 | 41632514 | PubTator, text mining | PubMed |
| Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes. | Comput Struct Biotechnol J | 2026 | 41550140 | PubTator, text mining | PubMed |
| RNA as a genome architect: G-loops in G-quadruplex regulation. | Mil Med Res | 2026 | 41530872 | PubTator, text mining | PubMed |
| RNA polymerase II degradation triggered by DNA repair occurs in trans and independently of how the lesion is recognized. | Nucleic Acids Res | 2026 | 41505090 | PubTator, text mining | PubMed |
| Genotype-phenotype associations in a robust cohort of 69 patients with xeroderma pigmentosum across Türkiye: a multicentre study. | Br J Dermatol | 2026 | 41483010 | PubTator, text mining | PubMed |
| Involvement of CCCTC-binding factor (CTCF) in immunomodulation and epigenetic regulation of T helper cell differentiation during Non-Small Cell Lung Cancer (NSCLC). | Clin Immunol | 2026 | 41482170 | PubTator, text mining | PubMed |
| Liposomal Delivery of Pyronaridine as a Repurposed Inhibitor of ERCC1/XPF for the Sensitization of Colorectal Cancer Cells to Platinum Chemotherapeutics. | Mol Pharm | 2026 | 41466566 | PubTator, text mining | PubMed |
| The association between DNA repair genes polymorphisms and cisplatin-induced ototoxicity in cancer patients: a systematic review. | Per Med | 2025 | 41532599 | PubTator, text mining | PubMed |
| Ginsenoside Rh2 Suppresses the Fanconi Anemia Pathway by Inhibiting NF-κB-Mediated FANCL Transcription in Bladder Cancer. | Dose Response | 2025 | 41425456 | PubTator, text mining | PubMed |
| Pathogenic variants in affected and unaffected individuals from Indonesian familial cancer: a multigene panel analysis. | Sci Rep | 2025 | 41407742 | PubTator, text mining | PubMed |
| Molecular basis of XPF-ERCC1 targeting to SLX4-dependent DNA repair pathways. | Nat Commun | 2025 | 41402316 | PubTator, text mining | PubMed |
| CIP2A mediates mitotic recruitment of SLX4/MUS81/XPF to resolve replication stress-induced DNA lesions. | Nat Commun | 2025 | 41330930 | PubTator, text mining | PubMed |
| Small extracellular vesicles: connecting early life exposure outcomes to air pollution during pregnancy to early childhood health. | Environ Health | 2025 | 41316269 | PubTator, text mining | PubMed |
| Piperine Targets the FANCL/UBE2T Complex to Inhibit the FA Pathway and Sensitize Bladder Cancer to Cisplatin. | Dose Response | 2025 | 41306722 | PubTator, text mining | PubMed |
| Proteomic discovery of DEK and NUMA1 as new players in UV-induced DNA damage repair mechanisms. | Cell Death Discov | 2025 | 41285742 | PubTator, text mining | PubMed |
| XPF mediates 3' flap processing for FEN1-independent Okazaki fragment maturation. | bioRxiv | 2025 | 41279254 | PubTator, text mining | PubMed |
| The effects of sequential and continuous chelation on the dentine tubule penetration of a bioceramic sealer: a confocal laser scanning microscopy study. | BMC Oral Health | 2025 | 41250061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=3